Literature DB >> 17276780

Wilson's disease.

Aftab Ala1, Ann P Walker, Keyoumars Ashkan, James S Dooley, Michael L Schilsky.   

Abstract

Progressive hepatolenticular degeneration, or Wilson's disease, is a genetic disorder of copper metabolism. Knowledge of the clinical presentations and treatment of the disease are important both to the generalist and to specialists in gastroenterology and hepatology, neurology, psychiatry, and paediatrics. Wilson's disease invariably results in severe disability and death if untreated. The diagnosis is easily overlooked but if discovered early, effective treatments are available that will prevent or reverse many manifestations of this disorder. Studies have identified the role of copper in disease pathogenesis and clinical, biochemical, and genetic markers that can be useful in diagnosis. There are several chelating agents and zinc salts for medical therapy. Liver transplantation corrects the underlying pathophysiology and can be lifesaving. The discovery of the Wilson's disease gene has opened up a new molecular diagnostic approach, and could form the basis of future gene therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17276780     DOI: 10.1016/S0140-6736(07)60196-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  232 in total

1.  Renal tubular acidosis due to Wilson's disease presenting as metabolic bone disease.

Authors:  Atul Vijay Palkar; Makardhwaj Sarvadaman Shrivastava; Namita J Padwal; Rupal N Padhiyar; Nivedita Moulick
Journal:  BMJ Case Rep       Date:  2011-08-11

2.  Alagille syndrome and Wilson disease in siblings: a diagnostic conundrum.

Authors:  Meghan Amson; Esther Lamoureux; Nir Hilzenrat; Marc Tischkowitz
Journal:  Can J Gastroenterol       Date:  2012-06       Impact factor: 3.522

3.  Wilson's disease: A review of what we have learned.

Authors:  Kryssia Isabel Rodriguez-Castro; Francisco Javier Hevia-Urrutia; Giacomo Carlo Sturniolo
Journal:  World J Hepatol       Date:  2015-12-18

4.  Measurement of urinary copper excretion after 48-h d-penicillamine cessation as a compliance assessment in Wilson's disease.

Authors:  Karolina Dzieżyc; Tomasz Litwin; Grzegorz Chabik; Anna Członkowska
Journal:  Funct Neurol       Date:  2015 Oct-Dec

5.  Mutational analysis of ATP7B in Chinese Wilson disease patients.

Authors:  Rui Hua; Fang Hua; Yonggeng Jiao; Yu Pan; Xu Yang; Shanshan Peng; Junqi Niu
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

6.  Liver transplantation for Wilson disease.

Authors:  Andreea M Catana; Valentina Medici
Journal:  World J Hepatol       Date:  2012-01-27

7.  Carrier frequency of Wilson's disease in the Korean population: a DNA-based approach.

Authors:  Ja-Hyun Jang; Taeheon Lee; Sunghee Bang; Young-Eun Kim; Eun-Hae Cho
Journal:  J Hum Genet       Date:  2017-05-18       Impact factor: 3.172

Review 8.  Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes.

Authors:  P de Bie; P Muller; C Wijmenga; L W J Klomp
Journal:  J Med Genet       Date:  2007-08-23       Impact factor: 6.318

Review 9.  The genetics of Wilson disease.

Authors:  Irene J Chang; Si Houn Hahn
Journal:  Handb Clin Neurol       Date:  2017

10.  Efficient formation of the tandem thymine glycol/8-oxo-7,8-dihydroguanine lesion in isolated DNA and the mutagenic and cytotoxic properties of the tandem lesions in Escherichia coli cells.

Authors:  Bifeng Yuan; Yong Jiang; Yuesong Wang; Yinsheng Wang
Journal:  Chem Res Toxicol       Date:  2010-01       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.